← Open Payments lookup

MICHAEL TSOVKO: Open Payments

NPI 1447933502 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,026 in 171 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $2,084 · 2025 $3,026

Food & beverage: $2,915Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.20$445
ABBVIE INC.21$410
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$400
Neurocrine BioSciences, Inc.11$290
E.R. Squibb & Sons, L.L.C.34$253
Vanda Pharmaceuticals Inc.8$217
Otsuka America Pharmaceutical, Inc.13$212
Alkermes, Inc.5$203
Lundbeck LLC9$174
Takeda Pharmaceuticals U.S.A., Inc.10$153

Products named: VRAYLAR, CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, COBENFY, FANAPT, TRINTELLIX.

Industry payments across TX — which companies pay providers there.